Loading...
Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists
Given the intersection between diabetes mellitus and cardiovascular disease (CVD), pharmacologic agents used to treat type 2 diabetes mellitus must show cardiovascular safety. Comorbid conditions, including heart failure and chronic kidney disease, are increasingly prevalent in patients with diabete...
Na minha lista:
| Udgivet i: | J Am Coll Cardiol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7219531/ https://ncbi.nlm.nih.gov/pubmed/32327107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2020.02.056 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|